Geode Capital Management, LLC Century Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 991,595 shares of IPSC stock, worth $743,696. This represents 0.0% of its overall portfolio holdings.

Number of Shares

991,595

Previous 968,182 2.42%

Holding current value

$743,696

Previous $1.66 Million 39.52%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$1.0 - $1.72 $23,413 - $40,270	23,413 Added 2.42%	991,595 $1 Million
Q3 2024 Nov 12, 2024	BUY	$1.44 - $3.29 $46,964 - $107,300	32,614 Added 3.49%	968,182 $1.66 Million
Q2 2024 Aug 09, 2024	BUY	$2.46 - $4.05 $1.05 Million - $1.72 Million	424,977 Added 83.23%	935,568 $2.39 Million
Q1 2024 May 13, 2024	BUY	$3.19 - $5.32 $134,407 - $224,152	42,134 Added 8.99%	510,591 $2.13 Million
Q4 2023 Feb 13, 2024	BUY	$1.28 - $3.32 $4,825 - $12,516	3,770 Added 0.81%	468,457 $1.56 Million
Q3 2023 Nov 13, 2023	BUY	$2.0 - $3.23 $42,376 - $68,437	21,188 Added 4.78%	464,687 $929,000
Q2 2023 Aug 11, 2023	BUY	$2.91 - $3.53 $64,957 - $78,796	22,322 Added 5.3%	443,499 $1.4 Million
Q1 2023 May 15, 2023	BUY	$3.4 - $5.11 $38,923 - $58,499	11,448 Added 2.79%	421,177 $1.46 Million
Q4 2022 Feb 13, 2023	BUY	$4.84 - $11.58 $124,542 - $297,976	25,732 Added 6.7%	409,729 $2.1 Million
Q3 2022 Nov 14, 2022	BUY	$8.57 - $13.1 $863,041 - $1.32 Million	100,705 Added 35.55%	383,997 $3.8 Million
Q2 2022 Aug 12, 2022	BUY	$7.96 - $12.43 $122,480 - $191,260	15,387 Added 5.74%	283,292 $2.38 Million
Q1 2022 May 13, 2022	BUY	$11.62 - $15.92 $610,991 - $837,089	52,581 Added 24.42%	267,905 $3.37 Million
Q4 2021 Feb 11, 2022	BUY	$13.93 - $23.62 $148,117 - $251,151	10,633 Added 5.19%	215,324 $3.42 Million
Q3 2021 Nov 12, 2021	BUY	$20.8 - $31.93 $3.45 Million - $5.3 Million	166,023 Added 429.36%	204,691 $5.15 Million
Q2 2021 Aug 13, 2021	BUY	$22.45 - $29.34 $868,096 - $1.13 Million	38,668 New	38,668 $1.13 Million

Others Institutions Holding IPSC

# of Institutions

Shares Held

36.9M

Call Options Held

8.7K

Put Options Held

10.2K

View Full List

About Century Therapeutics, Inc.

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $44.2M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

More about IPSC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Century Therapeutics, Inc. Transaction History